LSE - Delayed Quote NOK

Borregaard ASA (0QB7.L)

Compare
168.20
+2.39
+(1.44%)
At close: July 22 at 8:29:32 AM GMT+1
Loading Chart for 0QB7.L
  • Previous Close 165.81
  • Open 168.40
  • Bid --
  • Ask --
  • Day's Range 167.40 - 169.00
  • 52 Week Range 123.00 - 192.20
  • Volume 537
  • Avg. Volume 8,670
  • Market Cap (intraday) --
  • Beta (5Y Monthly) 0.69
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Apr 30, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Borregaard ASA engages in the development, production, and marketing of specialized biomaterials and biochemicals in Norway, rest of Europe, the United States, Asia, and internationally. It operates in three segments: BioSolutions, BioMaterials, and Fine Chemicals. The BioSolutions segment develops, produces, and sells biopolymers for various applications, such as agrochemicals, batteries, industrial binders, and construction; and biovanillin for flavor and fragrance companies, as well as for food and beverage industry. The BioMaterials segment offers specialty cellulose for use as a raw material in the production of cellulose ethers, cellulose acetate, and other specialty products; and cellulose fibrils for industrial applications. The Fine Chemicals segment provides fine chemical intermediates for contrast agents; and advanced bioethanol products. Borregaard ASA was incorporated in 2012 and is headquartered in Sarpsborg, Norway.

www.borregaard.com

1,174

Full Time Employees

December 31

Fiscal Year Ends

--

Sector

--

Industry

Recent News: 0QB7.L

View More

Performance Overview: 0QB7.L

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .

YTD Return

0QB7.L
7.79%
MSCI WORLD (^990100-USD-STRD)
9.15%

1-Year Return

0QB7.L
8.32%
MSCI WORLD (^990100-USD-STRD)
0.53%

3-Year Return

0QB7.L
2.41%
MSCI WORLD (^990100-USD-STRD)
9.32%

5-Year Return

0QB7.L
105.30%
MSCI WORLD (^990100-USD-STRD)
89.57%

Compare To: 0QB7.L

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 0QB7.L

View More

Valuation Measures

Annual
As of
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    10.81%

  • Return on Assets (ttm)

    8.78%

  • Return on Equity (ttm)

    16.61%

  • Revenue (ttm)

    7.62B

  • Net Income Avi to Common (ttm)

    823M

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    82M

  • Total Debt/Equity (mrq)

    45.64%

  • Levered Free Cash Flow (ttm)

    302M

Research Analysis: 0QB7.L

View More

Company Insights: 0QB7.L

Research Reports: 0QB7.L

View More